fda glp-1 warning letters november 2025 issued 25 to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA sends warning letter after

Dose adjustments are common, and your doctor should monitor blood pressure monthly during GLP-1 treatment, especially in the first 3-6 months when weight loss is most rapid

This treatment is considered non-ablative, which means that the top layer of the skin remains intact following the procedure

Think of it as lighting a fire rather than being the fuel

Zinc release from protein kinase C as the common event during activation by lipid second messenger or reactive oxygen

Compared with basal insulin, both tirzepatide 5 mg and tirzepatide 15 mg were associated with increased odds of discontinuation of study medication due to adverse events (ESM Table 3)